Intervet Inc.

Erin Linn Strait

Ruud Philip Antoon Maria Segers

Mark A Mogler

Pravina Kitikoon

Kevin O'Connell

Zhisong Qiao

Brad Eddy

Erwin Van Den Born

Supraja Puttamreddy

Basav Nagaraj

The present invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The present invention also provides vaccine against influenza A virus comprising such vectors and/or nucleic acid constructs. The present invention further provides methods of making and using the vaccines alone, or in combination with other protective agents.

Swine influenza a virus vaccine

The present invention relates to vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. To a vaccine, and a kit of parts comprising the replicon particles and the oil adjuvant. Also to methods and uses of making and using the vaccine and the components of the kit.

Vaccination with replicon particles and oil adjuvant

The present invention relates to a method of vaccination. Specifically the invention regards to a prime-boost vaccination regimen for protecting a target animal against infection or disease caused by a virus, wherein the vaccination regimen comprises the administration to said target animal of a vaccine comprising a live attenuated form of said virus, followed by the administration to said target animal of a vaccine comprising an RP encoding one or more antigens from said virus.

Prime-boost vaccination regimen

The present invention is drawn to liquid stable swine vaccines that comprise a live porcine virus. The invention is also drawn to the manufacture of such vaccines and methods of vaccinating animal subjects with these vaccines.

Growing community of inventors

Spring Hill, KS, United States of America

Erin Linn Strait